Trend in Deaths Among Men
Men have experienced a fluctuating yet overall increasing trend in deaths due to
myelodysplastic syndrome in
Spain, with the lowest recorded number being
438 deaths in 2008 and the highest
707 deaths in 2017. The numbers reveal a significant increase of
269 deaths over this period, indicating a growing impact of the
disease on the male
population.
Trend in Deaths Among Women
Women have shown a more stable pattern in
mortality rates from myelodysplastic syndrome, with a gradual increase from
294 deaths in 2006 to
517 deaths in 2015, followed by a slight fluctuation. The peak for women was observed in
2015 and 2016, each with over
500 deaths, highlighting a critical period for
female health concern related to this syndrome.
Gender Disparity in Mortality
Throughout the years 2005-2022, men consistently reported higher numbers of deaths from myelodysplastic syndrome than women, with a notable difference reaching up to
209 more deaths in men than women in 2017. This disparity underscores a significant gender-based difference in the impact of the disease.
Yearly Variability and Peak Incidents
The data exhibits noticeable yearly fluctuations in deaths among both genders, with
2017 marking the year of maximum deaths for men (
707) and
2015 and 2016 for women (with over
500 deaths each). These variations suggest the influence of external factors or possibly changes in
diagnosis or treatment efficacy over time.
Long-term Growth in Mortality Rates
Over the 18-year span from 2005 to 2022, there has been a general upward trend in mortality from myelodysplastic syndrome for both men and women, indicating an increasing burden of the disease in Spain. The cumulative increase highlights the need for enhanced medical and policy attention towards this condition.
Comparison with the Earliest and Latest Recorded Data
Comparing the earliest (
2005) and the latest data points (
2022), there has been an increase of
42.11% in male deaths and
34.87% in female deaths. This comparison showcases a significant rise in fatalities over nearly two decades, emphasizing the growing challenge myelodysplastic syndrome poses to public health.
Overall Mortality Increase
The total
number of deaths from myelodysplastic syndrome has risen from
810 in 2005 to
1,126 in 2022, marking an overall increase of
39%. This comprehensive growth reflects an escalating health concern that requires ongoing research and improved treatment strategies.